Team:Manchester/managementtest3

From 2013.igem.org

(Difference between revisions)
 
(11 intermediate revisions not shown)
Line 1: Line 1:
{{:Team:Manchester/layout/noheader}}
{{:Team:Manchester/layout/noheader}}
-
{{:Team:Manchester/Navbartest2}}
+
{{:Team:Manchester/Navbartest3}}
{{:Team:Manchester/Footer}}
{{:Team:Manchester/Footer}}
Line 137: Line 137:
font-weight:bold;
font-weight:bold;
color:#660099;
color:#660099;
-
text-shadow: 0 1px 0 #ccc,
+
 
-
              0 2px 0 #c9c9c9,
+
-
              0 3px 0 #bbb,
+
-
              0 4px 0 #b9b9b9,
+
-
              0 5px 0 #aaa,
+
-
              0 6px 1px rgba(0,0,0,.1),
+
-
              0 0 5px rgba(0,0,0,.1),
+
-
              0 1px 3px rgba(0,0,0,.3),
+
-
              0 3px 5px rgba(0,0,0,.2),
+
-
              0 5px 10px rgba(0,0,0,.25),
+
-
              0 10px 10px rgba(0,0,0,.2),
+
-
              0 20px 20px rgba(0,0,0,.15);
+
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
Line 164: Line 153:
color:#4c0082;
color:#4c0082;
 +
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
}
 +
 +
.text1 img
 +
{
 +
float:right;
 +
margin:10px 5px 5px 20px;
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
Line 182: Line 180:
{
{
float:right;
float:right;
 +
}
 +
 +
.text1 a
 +
{
 +
font-style:Trebuchet MS;
 +
font-size:14px;
 +
color:#4c0082;
}
}
Line 326: Line 331:
position:fixed;
position:fixed;
top:120px;
top:120px;
-
right:5px;
+
right:15px;
}
}
Line 368: Line 373:
.question3 a
.question3 a
{
{
 +
background:#bc80ea;
margin-top:1px;
margin-top:1px;
margin-bottom:1px;
margin-bottom:1px;
Line 448: Line 454:
<div class="wrapper" >
<div class="wrapper" >
             <div class="container1">
             <div class="container1">
-
             <a href="#"><img src="https://static.igem.org/mediawiki/2013/6/62/Man4.jpg" width="300" height="150" /></a>
+
             <a href="https://static.igem.org/mediawiki/2013/9/9c/MANCHESTERIGEMimpactanalysisofsyntheticpalmoil.pdf"><img src="https://static.igem.org/mediawiki/2013/6/62/Man4.jpg" width="300" height="150" /></a>
-
<p>When doing the initial research for our synthetic alternative to palm oil components, we quickly came across lots of information regarding the current palm oil industry. It soon became apparent that the economies of some countries, for example Indonesia and Malaysia, depend almost entirely upon the current methods of palm oil production. Therefore we compiled <b>an impact analysis report for synthetic palm oil</b>, which can be found by clicking on the button to the right.</p>
+
<p>When doing the initial research for our synthetic alternative to palm oil components, we quickly came across lots of information regarding the current palm oil industry. It soon became apparent that the economies of some countries, for example Indonesia and Malaysia, depend almost entirely upon the current methods of palm oil production. Therefore we compiled <b>a detailed impact analysis report for synthetic palm oil</b>, which can be found by clicking on the button to the right.</p>
             </div>
             </div>
Line 457: Line 463:
             <div class="text1">
             <div class="text1">
-
             <img src="https://static.igem.org/mediawiki/2013/b/b3/Man3.jpg" width="450" height="550" />
+
             <img src="https://static.igem.org/mediawiki/2013/2/27/Biotechcluster.png" width="450" height="550" />
-
             <p>Should we successfully patent our project and be able to licence it out to another country, the problem of exactly who should receive the licence arises. A few options present themselves. The technology could be given to an academic institution, a relevant industry or to the government itself. </p>
+
             <p>Should we successfully patent our project and be able to licence it out to another country, the problem of exactly <i>who</i> should receive the licence arises. A few options present themselves. The technology could be given to an academic institution, a relevant industry or to the government itself. </p>
 +
<br>
 +
<p>Before deciding whether it would be best to licence the project out to academia or a government body, it’s necessary to evaluate the current infrastructure available from each sector, and make sure that the sector can properly accommodate the technology. Here we focus primarily on Malaysia, with a view that Indonesia will have similar policies and services available to it.</p>
 +
<br>
 +
<p><b>Academia</b></p>
 +
<ul><li>Several universities in Malaysia offer Ph.D courses in Biotechnology, indicating that this is currently an active research area<sup>[1]</sup></li><br>
 +
<li>Institutes such as Agro-Biotechnology Institute Malaysia (ABI) often collaborate with universities on a variety of projects<sup>[2]</sup></li></ul>
 +
<br>
 +
<p><b>Government</b></p>
 +
<ul><li>Malaysia has a Ministry of Science, Technology and Innovation (MOSTI) - this has a Biotechnology cluster<sup>[3]</sup></li><br>
 +
<li>Cluster members provide services and facilities to help support programmes for the National Biotechnology Policy, each member may be in the position to accommodate the technology associated with this project</li><br>
 +
<li>Genom Malaysia is a not-for-profit organisation that works on the generation new IPs and technologies to aid economic growth, with a focus on areas such as metabolic engineering<sup>[4]</sup></li></ul>
 +
<br>
 +
Upon researching the options, we can conclude that issuing the patent licence out to a government body such as Genom Malaysia, rather than a specific university, would be the best scenario. This is because the facilities are already in place for government bodies to take up the project and get the most out of it. Collaborations with universities could be established via the ABI once the technology is up and running in an attempt to further optimise the processes if the need arises.
 +
 
 +
<br></br>
 +
<b>References</b><br>
 +
[1] <a href="http://www.mohe.gov.my/educationmsia/profile.php?code=AIMST" target="_blank">Education Malaysia. Institution Profile: AIMST University</a><br>
 +
[2] <a href="http://www.abi-nibm.my/" target="_blank">Malaysia Agro-Biotechnology Institute</a><br>
 +
[3] <a href="http://www.mosti.gov.my/index.php?option=com_content&view=category&id=42%3Abiotechnology&layout=blog&Itemid=258&lang=en" target="_blank">Ministry of Science, Technology and Innovation Malaysia. MOSTI Biotechnology cluster</a><br>
 +
[4] <a href="http://www.genomemalaysia.gov.my/v3/" target="_blank">Genom Malaysia</a></p></p>
-
<br>
 
-
LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN LOREM LOREM IPSUM LOREM LOREM LOREM LOREM LOREM LOREM LATIN MORE LATIN
 
             </div>  
             </div>  
Line 470: Line 494:
</div>
</div>
                
                
-
              <div class="leftbar">
+
               
-
                <div class="block1">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/HumanPracticetest">HUMAN PRACTICES</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block2">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/outreachtest">PUBLIC OUTREACH</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block3">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/stars">SCIENCE STARS</a>
+
-
                  </div>
+
-
                   
+
-
                  <div class="block4">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/openday">OPEN DAY</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block5">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/ethicstest">ETHICS</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block6">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/environmenttest">ENVIRONMENTAL IMPACT</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block7">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/economytest">ECONOMICAL IMPACT</a>
+
-
                  </div>
+
-
                   
+
-
                  <div class="block8">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/managementtest">IMPACT MANAGEMENT</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block9">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/conclusiontest">CONCLUSION</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block10">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/businesstest">BUSINESS PLAN</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block11">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/knoledgetest">KNOWLEDGE DEFICIT ASSUMPTION</a>
+
-
                  </div>
+
-
                   
+
-
                  <div class="block12">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/conferencetest">CONFERENCES AND DISCUSSIONS</a>
+
-
                  </div>
+
-
 
+
-
                  <div class="block13">
+
-
                    <a href="https://2013.igem.org/Team:Manchester/socialtest">SOCIAL MEDIA</a>
+
-
                  </div>
+
-
              </div>
+
-
 
+
-
                <div class="rightbar">
+
-
              <div class="question1">
+
-
              <a href="https://2013.igem.org/Team:Manchester/managementtest">Is The Palm Oil Industry Irreplaceable?</a>
+
-
              </div>
+
-
 
+
-
              <div class="question2">
+
-
  <a href="https://2013.igem.org/Team:Manchester/managementtest2">To Patent, Or Not To Patent, That Is The Question</a>
+
-
              </div>
+
-
 
+
-
            <div class="question3">
+
-
              <a href="https://2013.igem.org/Team:Manchester/managementtest3">Academia Vs. Government</a>
+
-
              </div>
+
-
 
+
-
            <div class="question4">
+
-
              <a href="https://2013.igem.org/Team:Manchester/managementtest4">Could Synthetic Palm Oil and Natural Palm Oil Exist In Harmony?
+
-
</a>
+
-
              </div>                 
+
-
            </div>                 
+
</div>
</div>
              
              

Latest revision as of 15:17, 4 October 2013

page

Top

Safety

When doing the initial research for our synthetic alternative to palm oil components, we quickly came across lots of information regarding the current palm oil industry. It soon became apparent that the economies of some countries, for example Indonesia and Malaysia, depend almost entirely upon the current methods of palm oil production. Therefore we compiled a detailed impact analysis report for synthetic palm oil, which can be found by clicking on the button to the right.

Academia Vs. Government

Should we successfully patent our project and be able to licence it out to another country, the problem of exactly who should receive the licence arises. A few options present themselves. The technology could be given to an academic institution, a relevant industry or to the government itself.


Before deciding whether it would be best to licence the project out to academia or a government body, it’s necessary to evaluate the current infrastructure available from each sector, and make sure that the sector can properly accommodate the technology. Here we focus primarily on Malaysia, with a view that Indonesia will have similar policies and services available to it.


Academia

  • Several universities in Malaysia offer Ph.D courses in Biotechnology, indicating that this is currently an active research area[1]

  • Institutes such as Agro-Biotechnology Institute Malaysia (ABI) often collaborate with universities on a variety of projects[2]

Government

  • Malaysia has a Ministry of Science, Technology and Innovation (MOSTI) - this has a Biotechnology cluster[3]

  • Cluster members provide services and facilities to help support programmes for the National Biotechnology Policy, each member may be in the position to accommodate the technology associated with this project

  • Genom Malaysia is a not-for-profit organisation that works on the generation new IPs and technologies to aid economic growth, with a focus on areas such as metabolic engineering[4]

Upon researching the options, we can conclude that issuing the patent licence out to a government body such as Genom Malaysia, rather than a specific university, would be the best scenario. This is because the facilities are already in place for government bodies to take up the project and get the most out of it. Collaborations with universities could be established via the ABI once the technology is up and running in an attempt to further optimise the processes if the need arises.

References
[1] Education Malaysia. Institution Profile: AIMST University
[2] Malaysia Agro-Biotechnology Institute
[3] Ministry of Science, Technology and Innovation Malaysia. MOSTI Biotechnology cluster
[4] Genom Malaysia